Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03971955 · ClinicalTrials.gov registry record
CharacterIzation of Adult Onset Autoimmune Diabetes
A clinical trial of Diabetes, sponsored by AdventHealth Translational Research Institute.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03971955: Active study of Diabetes, sponsored by AdventHealth Translational Research Institute.
NCT03971955 is a study of Diabetes that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 25 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03971955, a study of Diabetes, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to identify new biomarkers of Adult Onset Autoimmune Diabetes (AOnAD).
Primary Outcome
A change in the levels of specific microRNAs (miRNA) isolated from circulating exosomes.
Conditions Studied
Interventions
- PROCEDURE Adipose Tissue Biopsy
- OTHER Mixed Meal Test
- OTHER Dual Energy X-Ray Absorptiometry (DEXA)
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-07-08 |
| Est. Completion | 2025-12 |
What the registry record for NCT03971955 still lists
NCT03971955 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Adipose Tissue Biopsy is the first listed.
NCT03971955 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03971955 about?
NCT03971955 is a clinical study titled "CharacterIzation of Adult Onset Autoimmune Diabetes". The purpose of the study is to identify new biomarkers of Adult Onset Autoimmune Diabetes (AOnAD).
What is the current status of trial NCT03971955?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2019-07-08. Estimated completion is 2025-12.
What conditions does trial NCT03971955 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT03971955?
The interventions under investigation include: Adipose Tissue Biopsy (PROCEDURE), Mixed Meal Test (OTHER), Dual Energy X-Ray Absorptiometry (DEXA) (OTHER).
Who is sponsoring clinical trial NCT03971955?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03971955 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03971955's enrollment target sits among peer trials
25 294th of 338 higher than 42 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI